市場調查報告書
商品編碼
1466067
採血設備市場:按產品、方法、材料、應用和最終用戶分類 - 全球預測 2024-2030Blood Collection Devices Market by Product (Blood Collection Needles/Holders, Blood Collection System, Blood Collection Tubes), Method (Automated Blood Collection, Manual Blood Collection), Material, Application, End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年血液採樣設備市場規模為76.3億美元,預計2024年將達81.5億美元,2030年將達到125.2億美元,複合年成長率為7.32%。
血液採樣裝置是醫療領域用於提取人體血液用於診斷、治療監測、捐血和研究的專用設備。這些設備旨在確保血液採集過程的安全性、準確性和效率。血液採集設備對於最大限度地降低污染風險、確保血液樣本的完整性以及減少血液採集過程中的不適至關重要。全球血液相關疾病和慢性病病例的增加推動了血液檢測的需求並推動了市場的成長。此外,私營和公共部門不斷增加的醫療保健投資正在推動市場創新。然而,血液採樣設備的召回正在迅速增加,影響了市場的擴張。此外,採血方法和採血設備的技術創新正在提供更有效率、侵入性更小、更安全的採血方法,推動市場向前發展。
主要市場統計 | |
---|---|
基準年[2023] | 76.3億美元 |
預測年份 [2024] | 81.5億美元 |
預測年份 [2030] | 125.2億美元 |
複合年成長率(%) | 7.32% |
產品 血液採集系統不斷進步,促進無縫血液採集過程
採血針和採血支架是靜脈穿刺過程中使用的重要設備,可以安全有效地從病人身上提取血液樣本。這些設備經過專門設計,可最大程度地減少患者不適,同時確保血液樣本的完整性,從而獲得準確的診斷結果。血液採集系統包括各種設備,包括真空管、注射器和血液採集過程中的其他重要配件。這些系統旨在促進從穿刺到儲存的無縫血液採集過程,並確保血液處理的安全性和效率。先進的系統還具有降低污染風險和提高樣品品質的功能。採血管是血液採集和分析過程的重要組成部分。有許多不同類型的採血管,每種都設計用於特定的測試或分析,例如化學、血液學或血清學研究。它還可能含有添加劑和抗凝血劑,以保持血液樣本的完整性並防止凝血。血漿採血管是專門設計的採血管,含有抗凝血劑以防止血液凝固,對於需要血漿樣本的測試至關重要。透過離心將血漿與血球分離,並用於各種診斷測試,例如測量荷爾蒙水平和病毒量。血清管旨在促進血清的收集,血清是血栓後殘留的液體部分。這些管子通常不含抗凝血劑。血清管通常用於生化分析和疾病篩檢,因為它們產生不含血球的透明液體。採血針是一種小型、鋒利的儀器,用於通常從指尖採集毛細血管血液,特別是用於糖尿病管理中的血糖測試和其他需要少量血液的診斷測試。此一次性設備的設計以患者舒適和安全為首要考慮,並包括防止意外針刺和交叉污染的機制。
應用 人們對早期診斷的認知不斷增強,推動了採血設備的創新
診斷領域佔據了血液採樣設備市場的很大一部分。血液採樣裝置是準確診斷和監測各種疾病和狀況的必備設備。以安全有效的方式採集血液樣本,以最大限度地降低污染風險。採血設備廣泛應用於實驗室、醫院和診所,用於疾病檢測、血型和血液成分測量等診斷目的。血液採樣裝置的治療應用需要收集血液用於治療目的。這包括血漿置換、治療性靜脈切開術和捐血。用於治療用途的血液採集設備旨在安全有效地採集大量血液及其成分。治療部門受益於接受貧血和癌症等各種疾病治療和手術的患者對輸血和血液成分不斷成長的需求。
區域洞察
由於醫療保健設施強大以及確保安全性和有效性的法律規範,美洲地區對採血設備的需求仍然很高。持續的創新致力於使血液採集過程更安全、更舒適。正在投資自動化採血設備和整合數位技術。客戶的購買行為強調品質、可靠性和技術先進性。歐盟 (EU) 國家對醫療設備(包括採血設備)有嚴格的規定。重點是安全性、準確性和微創採血技術。歐洲市場的特點是對環境永續和符合人體工學的設備有很高的需求。歐盟的研究和投資旨在減少一次性設備的環境足跡,同時維持臨床有效性。由於對醫院基礎設施和醫療技術的大量投資,中東醫療保健產業正在經歷顯著成長。亞太地區快速擴張的醫療保健產業正在推動對採血設備的需求。該地區國家在醫療保健政策方面實施了重要改革,從而吸引了國內外市場相關人員的投資。特別是,創新集中在一次性、易於使用的設備上。
FPNV定位矩陣
FPNV 定位矩陣對於評估採血設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對血液採集設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.採血管市場規模及預測如何?
2.在血液採集設備市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.採血設備市場的技術趨勢和法規結構是什麼?
4.採血設備市場主要廠商的市場佔有率為何?
5.進入採血管市場合適的型態和策略手段是什麼?
[184 Pages Report] The Blood Collection Devices Market size was estimated at USD 7.63 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 7.32% to reach USD 12.52 billion by 2030.
Blood collection devices are specialized instruments used in the medical field to extract human blood for diagnostic purposes, treatment monitoring, blood donations, and research. These devices are designed to assure the safety, accuracy, and efficiency of the blood collection process. Blood collection devices are crucial in minimizing the risk of contamination, assuring the integrity of the blood sample, and reducing discomfort during the collection process. The increasing cases of blood-related disorders and chronic diseases globally drive the demand for blood tests, fueling the market's growth. In addition, rising healthcare investments from the private & public sectors boost innovation in the market. However, the surging incidence of blood collection device recall impacts the expansion of the market. Furthermore, innovations in blood collection methods and devices offer more efficient, less invasive, and safer options for blood collection, pushing the market forward.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.63 billion |
Estimated Year [2024] | USD 8.15 billion |
Forecast Year [2030] | USD 12.52 billion |
CAGR (%) | 7.32% |
Product: Ongoing advancements blood collection systems to facilitate a seamless collection process
Blood collection needles and holders are critical devices used for venipuncture procedures, enabling the safe and efficient extraction of blood samples from patients. These devices are specifically designed to minimize patient discomfort while ensuring the integrity of the blood sample for accurate diagnostic results. Blood collection systems encompass a wide range of devices, including vacuum tubes, syringes, and other accessories essential for blood draw procedures. These systems are designed to facilitate a seamless collection process, from puncture to storage, ensuring the safety and efficiency of blood handling. Advanced systems also incorporate features that reduce contamination risk and improve sample quality. Blood collection tubes are an indispensable part of the blood collection and analysis process. These tubes come in various types, each designed for specific tests or analyses, including chemical, hematological, and serological investigations. They may contain additives and anticoagulants that preserve the integrity of the blood sample and prevent clotting. Plasma blood tubes are specially designed tubes containing anticoagulants that prevent blood from clotting, making them essential for tests that require plasma samples. The plasma is isolated from the blood cells by centrifugation, and it is used for a variety of diagnostic tests, including hormone levels and viral load measurements. Serum tubes are designed to facilitate the collection of serum, which is the liquid portion of blood that remains after clotting has occurred. These tubes generally do not contain anticoagulants. Serum tubes are commonly used for biochemical analyses and disease screening, as they provide a clear liquid free from blood cells. Lancets are small, sharp instruments used for capillary blood sampling, typically from a fingertip, especially in diabetes management for glucose testing, as well as in other diagnostic tests requiring small amounts of blood. Designed for single use, these devices prioritize patient comfort and safety, featuring mechanisms to prevent accidental needlesticks and cross-contamination.
Application: Growing awareness about early diagnosis driving the innovations of blood collection devices
The diagnostic segment holds a significant portion of the market for blood collection devices. These devices are essential for accurate diagnosis and monitoring of various diseases and conditions. They facilitate the collection of blood samples in a safe, efficient manner, minimizing the risk of contamination. Blood collection devices are extensively used in laboratories, hospitals, and clinics for diagnostic purposes, including blood tests for disease detection, blood typing, and the measurement of blood components. Therapeutic applications of blood collection devices entail procedures that require blood withdrawal for treatment purposes. These include plasmapheresis, therapeutic phlebotomy, and blood donations. Blood collection devices in therapeutic applications are designed to collect blood and its components in larger volumes safely and efficiently. The therapeutic segment benefits from the rising demand for blood transfusions and blood components in the treatment of various diseases, such as anemia and cancer, and for patients undergoing surgeries.
Regional Insights
In the American region, the demand for blood collection devices remains high due to the strong presence of healthcare facilities and a robust regulatory framework ensuring safety and efficacy. Ongoing innovations have focused on enhancing the safety and comfort of blood collection processes. Investments are directed towards automation and integration of digital technologies in collection devices. Customer purchasing behavior emphasizes quality, reliability, and technological advancements. European Union countries have stringent regulations governing medical devices, including blood collection devices. The focus is on safety, precision, and minimizing the invasiveness of blood collection techniques. The European market is distinguished by high demand for devices that are environmentally sustainable and ergonomic. Research and investment in the EU aim to reduce the ecological footprint of disposable devices while maintaining their clinical efficacy. The Middle East has been witnessing substantial growth in the healthcare sector, with significant investments in hospital infrastructure and medical technology. The APAC's rapidly expanding healthcare sector is propelling the demand for blood collection devices. The countries across the region have implemented significant reforms in healthcare policies, thereby attracting investments in both domestic and international market players. Innovations are particularly focused on disposable and user-friendly devices.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Blood Collection Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Collection Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Blood Collection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Avanos Medical, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Exelint International, Co., Fresenius SE & Co. KGaA, Greiner AG, Haemonetics Corporation, ICU Medical, Inc., ITL Health Group, Kawasumi Laboratories America, Inc., Lasany International, Medtronic PLC, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Blood Collection Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Collection Devices Market?
3. What are the technology trends and regulatory frameworks in the Blood Collection Devices Market?
4. What is the market share of the leading vendors in the Blood Collection Devices Market?
5. Which modes and strategic moves are suitable for entering the Blood Collection Devices Market?